The Cocktail Report (sound really smart around your friends):
Researchers measured thousands of proteins in healthy ovaries from 28 women aged 50 to 75.
117 proteins differed between ovaries from women in their 50s and those 70 and older.
Older ovaries leaned toward immune and inflammation proteins, while structural proteins such as collagens fell.
Known ovarian cancer markers, including CA125 and HE4, were highest in women in their 60s, even though no ovary had cancer.
The team packed the strongest changes into a 26-protein signature called BuckPOMS.
If you have been through menopause, you may have heard that your ovaries simply went quiet. A new study of healthy ovaries from 28 women says they keep changing for at least two more decades.
The work comes from the Buck Institute for Research on Aging in Novato, California, and Northwestern University, and was published this month in Aging Cell.
How the study worked
The ovaries came from women having surgery for non-cancer reasons, most often problems with the uterine lining such as endometriosis. A pathologist confirmed each ovary looked normal, and the women were 50 to 75 years old, with an average age of 63.
Using mass spectrometry, a lab method that weighs molecules to identify them, the team measured 5,812 proteins. They split the women into three groups: their 50s (11 women), their 60s, and 70 or older.
What changed with age
Between the youngest and oldest groups, 117 proteins differed significantly. Ovaries in the 50s leaned toward proteins that run gene activity, while ovaries in the 70s leaned toward metabolism, transport inside cells, and innate immunity, the body's fast first-line defense.
Proteins of the complement system, blood proteins that tag threats for the immune system, rose with age. Collagens, which give tissue its structure, fell, while secreted factors in the extracellular matrix (the scaffolding between cells) rose.
The team gathered the greatest changes into a 26-protein signature they named BuckPOMS. They checked two of its proteins, WNT4 and fibromodulin, by staining tissue slices under a microscope.
The cancer connection
Several known ovarian cancer markers, including CA125 and HE4, reached their highest average levels in ovaries from women in their 60s. That decade surrounds the median age at which ovarian cancer is diagnosed, about 63.
None of these ovaries had cancer. The authors suggest the aging ovary may drift toward a more "cancer-ready" setting even when it looks healthy.
What this means for you
If you are facing a hysterectomy and your surgeon has asked whether to remove the ovaries too, this study adds a new point to that talk. The authors note that removal clearly lowers ovarian cancer risk in high-risk BRCA1 and BRCA2 carriers, while early or routine removal brings higher long-term risks of heart disease, bone thinning, and declining thinking skills.
If you are in your 60s, that is the decade with the strongest cancer-marker signal in this group. Treat it as a reason to keep regular gynecology visits, not as a reason for alarm.
What this study does and does not show
To be frank, 28 women is a small group, and only 7 were 70 or older. The researchers did not know when each woman reached menopause, how long ago that was, or whether she had used hormone therapy.
Each woman gave tissue at a single point in time, so the study compares age groups rather than following one ovary as it ages. The study was not designed to test whether these protein shifts lead to disease, which the authors list as work still to be done.
Why Should You Care?
If the ovary keeps sending signals long after fertility ends, it may matter for women's health for decades. This study gives researchers a reference map to start testing that.
Watson MA, Soygur B, King CD, Devrukhkar PR, Melov S, Shanes ED, Pavone MEG, Duncan FE, Schilling B. "The Human Ovary Exhibits Dynamic Molecular Remodeling in the Decades Post-Menopause." Aging Cell. 2026;25(10):e70714. DOI: 10.1111/acel.70714. https://pmc.ncbi.nlm.nih.gov/articles/PMC13662414/
